Literature DB >> 8981712

Surveillance and control of epidemic keratoconjunctivitis.

J D Gottsch.   

Abstract

PURPOSE: The purpose of this study was to determine if the implementation of a formal set of infection-control policy and procedures (ICPPs) can reduce the number of outbreaks of epidemic keratoconjunctivitis (EKC) and the number of nosocomially infected patients in a large teaching eye institute.
METHODS: A retrospective and prospective study of the incidence of EKC and the number of affected patients was performed for the years 1984 through 1991. Infection-control measures (ICPPs) were formulated in 1992 with regulations implemented for patient control and management, hand washing, instrument disinfection, medication distribution, and employee furloughs. Two levels of ICPPs were established on the basis of nonepidemic or epidemic conditions. After implementation of ICPPs, a prospective 4-year study (1992 through 1995) and statistical analysis were performed to determine whether the number of outbreaks of EKC and affected patients significantly decreased.
RESULTS: The incidence of institutional EKC epidemics per year was at least one and as many as three from 1984 through 1991. After implementation of a formal set of ICPPs, no epidemics occurred in 2 of 4 years studied. The number of epidemics and affected patients was significantly less when the years before and after implementation of ICPPs were compared by chi-square analysis (P < .01 and P <. 01, respectively).
CONCLUSIONS: In this first prospective study of institutional outbreaks of EKC, the implementation of ICPPs was demonstrated to be an effective means to decrease the number of EKC outbreaks and nosocomially infected patients for this particular institution. Although several reports of institutional outbreaks of EKC have described infection-control measures that eventually controlled an outbreak well under way, this study provides policies and procedures that may effectively decrease the number and size of nosocomial epidemics of adenoviral conjunctivitis in large teaching eye institutions.

Entities:  

Mesh:

Year:  1996        PMID: 8981712      PMCID: PMC1312111     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  70 in total

1.  Apollo 11 disease or acute hemorrhagic conjunctivitis: a pandemic of a new enterovirus infection of the eyes.

Authors:  R Kono
Journal:  Am J Epidemiol       Date:  1975-05       Impact factor: 4.897

2.  The isolation of 21 strains of type 8 adenovirus from an outbreak of epidemic keratoconjunctivitis.

Authors:  J J QUILLIGAN; J ADRIAN; B ALENA
Journal:  Am J Ophthalmol       Date:  1959-08       Impact factor: 5.258

3.  The story of shipyard eye.

Authors:  E JAWETZ
Journal:  Br Med J       Date:  1959-04-04

4.  Office and dispensary transmissions of epidemic keratoconjunctivitis.

Authors:  P THYGESON
Journal:  Am J Ophthalmol       Date:  1957-04       Impact factor: 5.258

5.  new type of APC virus from epidemic keratoconjunctivitis.

Authors:  E JAWETZ; S KIMURA; A N NICHOLAS; P THYGESON; L HANNA
Journal:  Science       Date:  1955-12-16       Impact factor: 47.728

6.  Studies on the etiology of epidemic keratoconjunctivitis.

Authors:  E JAWETZ; S J KIMURA; L HANNA; V R COLEMAN; P THYGESON; A NICHOLAS
Journal:  Am J Ophthalmol       Date:  1955-11       Impact factor: 5.258

7.  Letter: Keratoconjunctivitis caused by Adenovirus Type 19.

Authors:  J Desmyter; J C De Jong; K W Slaterus; H Verlaeckt
Journal:  Br Med J       Date:  1974-11-16

8.  Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist's office.

Authors:  R A Keenlyside; J C Hierholzer; L J D'Angelo
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

9.  Acute hemorrhagic conjunctivitis: a mixed virus outbreak among Vietnamese refugees on Guam.

Authors:  A P Arnow; J C Hierholzer; J Higbee; D H Harris
Journal:  Am J Epidemiol       Date:  1977-01       Impact factor: 4.897

10.  Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control.

Authors:  J A Jernigan; B S Lowry; F G Hayden; S A Kyger; B P Conway; D H Gröschel; B M Farr
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

View more
  5 in total

Review 1.  Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey; A B Tullo
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  Human adenovirus: Viral pathogen with increasing importance.

Authors:  B Ghebremedhin
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

Review 3.  Treatment of viral conjunctivitis with antiviral drugs.

Authors:  Chrysanthi L Skevaki; Ioanna E Galani; Michail V Pararas; Konstantina P Giannopoulou; Athanassios Tsakris
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

4.  Evaluation of knowledge, attitude, and behaviour of ophthalmologists about adenoviral conjunctivitis transmission and treatment : An online survey for Turkish ophthalmologists.

Authors:  Gozde Sahin Vural; Ozlem Barut Selver; Melis Palamar
Journal:  Int Ophthalmol       Date:  2022-05-11       Impact factor: 2.029

Review 5.  SARS, avian flu, bioterror: infection control awareness for the optometrist.

Authors:  Santos Shan-Yu Tseng
Journal:  Clin Exp Optom       Date:  2007-01       Impact factor: 2.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.